High disaccharide intake associates with atherogenic lipoprotein profile. 2012

Emily Sonestedt, and Elisabet Wirfält, and Peter Wallström, and Bo Gullberg, and Isabel Drake, and Joanna Hlebowicz, and Gunilla Nordin Fredrikson, and Bo Hedblad, and Jan Nilsson, and Ronald M Krauss, and Marju Orho-Melander
Department of Clinical Sciences - Malmö, Lund University, SE-205 02 Malmö, Sweden. emily.sonestedt@med.lu.se

Increased plasma concentrations of small LDL particles denote an atherogenic lipoprotein phenotype (ALP) that is correlated with increased circulating TAG and reduced HDL-cholesterol. Principal component analyses of subfraction concentrations have previously been used in the Swedish population-based Malmö Diet and Cancer (MDC) cohort to identify three independent components, one pattern representing the ALP. The aim of the present study was to examine the associations between macronutrient intakes and the principal component representing the ALP. We examined 4301 healthy subjects (46-68 years old, 60 % women) at baseline in the MDC cohort. Dietary data were collected using a modified diet history method. Plasma lipoprotein subfractions were measured using a high-resolution ion mobility method. The principal component corresponding to the ALP was significantly associated with a higher intake of disaccharides, and inversely related to protein and alcohol consumption (P < 0·001 for all). The present findings indicate that the ALP may be improved by a low intake of disaccharides, and moderate intakes of protein and alcohol.

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004036 Diet, Atherogenic A diet that contributes to the development and acceleration of ATHEROGENESIS. Atherogenic Diet,Atherogenic Diets,Diets, Atherogenic
D004044 Dietary Proteins Proteins obtained from foods. They are the main source of the ESSENTIAL AMINO ACIDS. Proteins, Dietary,Dietary Protein,Protein, Dietary
D004187 Disaccharides Oligosaccharides containing two monosaccharide units linked by a glycosidic bond. Disaccharide

Related Publications

Emily Sonestedt, and Elisabet Wirfält, and Peter Wallström, and Bo Gullberg, and Isabel Drake, and Joanna Hlebowicz, and Gunilla Nordin Fredrikson, and Bo Hedblad, and Jan Nilsson, and Ronald M Krauss, and Marju Orho-Melander
July 1986, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Emily Sonestedt, and Elisabet Wirfält, and Peter Wallström, and Bo Gullberg, and Isabel Drake, and Joanna Hlebowicz, and Gunilla Nordin Fredrikson, and Bo Hedblad, and Jan Nilsson, and Ronald M Krauss, and Marju Orho-Melander
June 2014, Lipids in health and disease,
Emily Sonestedt, and Elisabet Wirfält, and Peter Wallström, and Bo Gullberg, and Isabel Drake, and Joanna Hlebowicz, and Gunilla Nordin Fredrikson, and Bo Hedblad, and Jan Nilsson, and Ronald M Krauss, and Marju Orho-Melander
September 2020, Pediatric obesity,
Emily Sonestedt, and Elisabet Wirfält, and Peter Wallström, and Bo Gullberg, and Isabel Drake, and Joanna Hlebowicz, and Gunilla Nordin Fredrikson, and Bo Hedblad, and Jan Nilsson, and Ronald M Krauss, and Marju Orho-Melander
December 2014, Analytical biochemistry,
Emily Sonestedt, and Elisabet Wirfält, and Peter Wallström, and Bo Gullberg, and Isabel Drake, and Joanna Hlebowicz, and Gunilla Nordin Fredrikson, and Bo Hedblad, and Jan Nilsson, and Ronald M Krauss, and Marju Orho-Melander
February 1982, MMW, Munchener medizinische Wochenschrift,
Emily Sonestedt, and Elisabet Wirfält, and Peter Wallström, and Bo Gullberg, and Isabel Drake, and Joanna Hlebowicz, and Gunilla Nordin Fredrikson, and Bo Hedblad, and Jan Nilsson, and Ronald M Krauss, and Marju Orho-Melander
April 2024, Heart rhythm,
Emily Sonestedt, and Elisabet Wirfält, and Peter Wallström, and Bo Gullberg, and Isabel Drake, and Joanna Hlebowicz, and Gunilla Nordin Fredrikson, and Bo Hedblad, and Jan Nilsson, and Ronald M Krauss, and Marju Orho-Melander
January 2017, Journal of diabetes research,
Emily Sonestedt, and Elisabet Wirfält, and Peter Wallström, and Bo Gullberg, and Isabel Drake, and Joanna Hlebowicz, and Gunilla Nordin Fredrikson, and Bo Hedblad, and Jan Nilsson, and Ronald M Krauss, and Marju Orho-Melander
November 2005, Metabolism: clinical and experimental,
Emily Sonestedt, and Elisabet Wirfält, and Peter Wallström, and Bo Gullberg, and Isabel Drake, and Joanna Hlebowicz, and Gunilla Nordin Fredrikson, and Bo Hedblad, and Jan Nilsson, and Ronald M Krauss, and Marju Orho-Melander
August 2009, Diabetes, obesity & metabolism,
Emily Sonestedt, and Elisabet Wirfält, and Peter Wallström, and Bo Gullberg, and Isabel Drake, and Joanna Hlebowicz, and Gunilla Nordin Fredrikson, and Bo Hedblad, and Jan Nilsson, and Ronald M Krauss, and Marju Orho-Melander
March 2020, Nutrients,
Copied contents to your clipboard!